Development and experimental validation of computational methods for human antibody affinity enhancement
Briefings in Bioinformatics · 2024
DOI: 10.1093/bib/bbae488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Briefings in Bioinformatics, 2024. Verfasst von Junxin Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of S…. Hauptthemen laut MEDLINE: Antibody Affinity, Complementarity Determining Regions, Computational Biology. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Key Research and Development Program of China, National Science Foundation of China, Shenzhen Basic Research Fund.
Abstract (Originalsprache)
High affinity is crucial for the efficacy and specificity of antibody. Due to involving high-throughput screens, biological experiments for antibody affinity maturation are time-consuming and have a low success rate. Precise computational-assisted antibody design promises to accelerate this process, but there is still a lack of effective computational methods capable of pinpointing beneficial mutations within the complementarity-determining region (CDR) of antibodies. Moreover, random mutations often lead to challenges in antibody expression and immunogenicity. In this study, to enhance the affinity of a human antibody against avian influenza virus, a CDR library was constructed and evolutionary information was acquired through sequence alignment to restrict the mutation positions and types. Concurrently, a statistical potential methodology was developed based on amino acid interactions between antibodies and antigens to calculate potential affinity-enhanced antibodies, which were further subjected to molecular dynamics simulations. Subsequently, experimental validation confirmed that a point mutation enhancing 2.5-fold affinity was obtained from 10 designs, resulting in the antibody affinity of 2 nM. A predictive model for antibody–antigen interactions based on the binding interface was also developed, achieving an Area Under the Curve (AUC) of 0.83 and a precision of 0.89 on the test set. Lastly, a novel approach involving combinations of affinity-enhancing mutations and an iterative mutation optimization scheme similar to the Monte Carlo method were proposed. This study presents computational methods that rapidly and accurately enhance antibody affinity, addressing issues related to antibody expression and immunogenicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Protein and Cell-based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen 518055, China.
- Department of Computational Biomedicine, Cedars-Sinai Medical Center, 8700 Beverly Blvd, Los Angeles, CA 90048, United States.
- Key Laboratory of Quantitative Synthetic Biology, Shenzhen Institute of Synthetic Biology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Nanshan District, Shenzhen 518055,…
- School of Chemistry and Molecular Engineering, East China Normal University, 3663 Zhongshan North Road, Putuo District, Shanghai 200062, China.
- Guangdong Key Laboratory of Nanomedicine, Shenzhen Engineering Laboratory of Nanomedicine and Nanoformulations, CAS Key Lab for Health Informatics, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences…
- Faculty of Synthetic Biology, Shenzhen University of Advanced Technology, Shenzhen 518055, China.
ORCID-Profile: John Z H Zhang, Haiping Zhang
Förderung
- National Key Research and Development Program of China
- National Science Foundation of China
- Shenzhen Basic Research Fund
- Guangdong Basic and Applied Basic Research Foundation
- Shenzhen Key Projects
Zitieren
APA
Li, J., Liao, L., Zhang, C., Huang, K., Zhang, P., Zhang, J. Z. H., Wan, X., & Zhang, H. (2024). Development and experimental validation of computational methods for human antibody affinity enhancement. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbae488
Vancouver
Li J, Liao L, Zhang C, Huang K, Zhang P, Zhang JZH, et al. Development and experimental validation of computational methods for human antibody affinity enhancement. Briefings in Bioinformatics. 2024. doi:10.1093/bib/bbae488
BibTeX
@article{Li2024,
author = {Li, Junxin and Liao, Linbu and Zhang, Chao and Huang, Kaifang and Zhang, Pengfei and Zhang, John Z H and Wan, Xiaochun and Zhang, Haiping},
title = {Development and experimental validation of computational methods for human antibody affinity enhancement},
journal = {Briefings in Bioinformatics},
year = {2024},
doi = {10.1093/bib/bbae488}
}
EUVIMED